Login / Signup

Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance, and their limitations.

Michaël HardyJonathan DouxfilsMarion BareilleSarah LessireIsabelle Gouin-ThibaultAndreas GreinacherThomas LecompteFrançois Mullier
Published in: Journal of thrombosis and haemostasis : JTH (2020)
Keyphrases
  • coronavirus disease
  • sars cov
  • adverse drug
  • case control
  • respiratory syndrome coronavirus
  • emergency department